Literature DB >> 10604470

Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

M Kojima1, H Hosoda, Y Date, M Nakazato, H Matsuo, K Kangawa.   

Abstract

Small synthetic molecules called growth-hormone secretagogues (GHSs) stimulate the release of growth hormone (GH) from the pituitary. They act through GHS-R, a G-protein-coupled receptor for which the ligand is unknown. Recent cloning of GHS-R strongly suggests that an endogenous ligand for the receptor does exist and that there is a mechanism for regulating GH release that is distinct from its regulation by hypothalamic growth-hormone-releasing hormone (GHRH). We now report the purification and identification in rat stomach of an endogenous ligand specific for GHS-R. The purified ligand is a peptide of 28 amino acids, in which the serine 3 residue is n-octanoylated. The acylated peptide specifically releases GH both in vivo and in vitro, and O-n-octanoylation at serine 3 is essential for the activity. We designate the GH-releasing peptide 'ghrelin' (ghre is the Proto-Indo-European root of the word 'grow'). Human ghrelin is homologous to rat ghrelin apart from two amino acids. The occurrence of ghrelin in both rat and human indicates that GH release from the pituitary may be regulated not only by hypothalamic GHRH, but also by ghrelin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10604470     DOI: 10.1038/45230

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  1877 in total

1.  The stomach talks with the pituitary.

Authors:  O Lundgren
Journal:  Gut       Date:  2000-08       Impact factor: 23.059

Review 2.  Growth hormone: new ideas, recurring themes.

Authors:  E O Reiter
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

3.  Reflections on growth hormone.

Authors:  R Deghenghi
Journal:  J Endocrinol Invest       Date:  2000 Jul-Aug       Impact factor: 4.256

Review 4.  Control of body weight: a physiologic and transgenic perspective.

Authors:  G Frühbeck; J Gómez-Ambrosi
Journal:  Diabetologia       Date:  2003-02-15       Impact factor: 10.122

Review 5.  Intranasally and orally active GH secretagogues are useful clinical tools: so why are they not on the market?

Authors:  Z Laron
Journal:  J Endocrinol Invest       Date:  2003-01       Impact factor: 4.256

Review 6.  Ghrelin: the link connecting growth with metabolism and energy homeostasis.

Authors:  Felipe F Casanueva; Carlos Dieguez
Journal:  Rev Endocr Metab Disord       Date:  2002-12       Impact factor: 6.514

7.  Identification and localization of the fatty acid modification in ghrelin by electron capture dissociation.

Authors:  Ziqiang Guan
Journal:  J Am Soc Mass Spectrom       Date:  2002-12       Impact factor: 3.109

8.  Involvement of p38 MAPK-dependent activator protein (AP-1) activation in modulation of gastric mucosal inflammatory responses to Helicobacter pylori by ghrelin.

Authors:  B L Slomiany; A Slomiany
Journal:  Inflammopharmacology       Date:  2012-06-06       Impact factor: 4.473

9.  Growth hormone and somatostatin directly inhibit gastric ghrelin secretion. An in vitro organ culture system.

Authors:  L M Seoane; O Al-Massadi; F Barreiro; C Dieguez; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2007-10       Impact factor: 4.256

10.  Seven transmembrane G protein-coupled receptor repertoire of gastric ghrelin cells.

Authors:  Maja S Engelstoft; Won-Mee Park; Ichiro Sakata; Line V Kristensen; Anna Sofie Husted; Sherri Osborne-Lawrence; Paul K Piper; Angela K Walker; Maria H Pedersen; Mark K Nøhr; Jie Pan; Christopher J Sinz; Paul E Carrington; Taro E Akiyama; Robert M Jones; Cong Tang; Kashan Ahmed; Stefan Offermanns; Kristoffer L Egerod; Jeffrey M Zigman; Thue W Schwartz
Journal:  Mol Metab       Date:  2013-09-04       Impact factor: 7.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.